64 related articles for article (PubMed ID: 6184813)
21. [Interferon-alpha, beta, gamma].
Imanishi J
Gan To Kagaku Ryoho; 1994 Dec; 21(16):2853-8. PubMed ID: 7993128
[TBL] [Abstract][Full Text] [Related]
22. Stimulation of gamma interferon production by TPA and related diterpene esters.
Vilcek J; Yip YK; Stone-Wolff DS; Pang RH
Tex Rep Biol Med; 1981-1982; 41():108-15. PubMed ID: 6817435
[No Abstract] [Full Text] [Related]
23. Interferon-gamma-mediated pathways and in vitro PBMC proliferation in HIV-infected patients.
Schroecksnadel K; Winkler C; Werner ER; Sarcletti M; Romani N; Ebner S; Schennach H; Fuchs D; Zangerle R
Biol Chem; 2009 Feb; 390(2):115-23. PubMed ID: 19040353
[TBL] [Abstract][Full Text] [Related]
24. Factors influencing the production of human immune interferon components.
Van Damme J; De Ley M; Muylle L; Billiau A
Dev Biol Stand; 1983; 55():135-41. PubMed ID: 6428953
[TBL] [Abstract][Full Text] [Related]
25. Enhancement of antiviral activity against hepatitis C virus in vitro by interferon combination therapy.
Okuse C; Rinaudo JA; Farrar K; Wells F; Korba BE
Antiviral Res; 2005 Jan; 65(1):23-34. PubMed ID: 15652968
[TBL] [Abstract][Full Text] [Related]
26. Glucan phosphate potentiates endotoxin-induced interferon-gamma expression in immunocompetent mice, but attenuates induction of endotoxin tolerance.
Sherwood ER; Varma TK; Fram RY; Lin CY; Koutrouvelis AP; Toliver-Kinsky TE
Clin Sci (Lond); 2001 Dec; 101(6):541-50. PubMed ID: 11724637
[TBL] [Abstract][Full Text] [Related]
27. Adenovirus-mediated murine interferon-gamma receptor transfer enhances the efficacy of IFN-gamma in vivo.
Nishida Y; Maeda Y; Hara A; Arima T; Kimura E; Yamashita S; Uyama E; Mita S; Uchino M
Biochem Biophys Res Commun; 2002 Jan; 290(3):1042-7. PubMed ID: 11798180
[TBL] [Abstract][Full Text] [Related]
28. The reduction of voluntary physical activity after poly I:C injection is independent of the effect of poly I:C-induced interferon-beta in mice.
Matsumoto T; Takahashi H; Shiva D; Kawanishi N; Kremenik MJ; Kato Y; Yano H
Physiol Behav; 2008 Mar; 93(4-5):835-41. PubMed ID: 18191426
[TBL] [Abstract][Full Text] [Related]
29. Human interferon-gamma has three domains associated with its antiviral function: a neutralizing epitope typing scheme for human interferon-gamma.
Kwok AY; Zu X; Yang C; Alfa MJ; Jay FT
Immunology; 1993 May; 79(1):131-7. PubMed ID: 7685313
[TBL] [Abstract][Full Text] [Related]
30. Synergism between interferon-gamma and cAMP in induction of hepatocyte growth factor in human skin fibroblasts.
Gohda E; Kuromitsu K; Matsunaga T; Miyazaki M; Yamamoto I
Cytokine; 2000 Jun; 12(6):780-5. PubMed ID: 10843764
[TBL] [Abstract][Full Text] [Related]
31. Association of human leucocyte low responsiveness to inducers of interferon alpha with HLA-DR 2.
Abb J; Zander H; Abb H; Albert E; Deinhardt F
Immunology; 1983 Jun; 49(2):239-44. PubMed ID: 6406360
[TBL] [Abstract][Full Text] [Related]
32. Unique keratinocyte-specific effects of interferon-gamma that protect skin from viruses, identified using transcriptional profiling.
Banno T; Adachi M; Mukkamala L; Blumenberg M
Antivir Ther; 2003 Dec; 8(6):541-54. PubMed ID: 14760888
[TBL] [Abstract][Full Text] [Related]
33. Interferon induction in mouse spleen cells by mitogenic and nonmitogenic lectins.
Ito Y; Tsurudome M; Yamada A; Hishiyama M
J Immunol; 1984 May; 132(5):2440-4. PubMed ID: 6201544
[TBL] [Abstract][Full Text] [Related]
34. Interferon-gamma is a potent inducer of catagen-like changes in cultured human anagen hair follicles.
Ito T; Ito N; Saathoff M; Bettermann A; Takigawa M; Paus R
Br J Dermatol; 2005 Apr; 152(4):623-31. PubMed ID: 15840090
[TBL] [Abstract][Full Text] [Related]
35. Interferon-gamma and interferon-beta affect endogenous catecholamines in human peripheral blood mononuclear cells: implications for multiple sclerosis.
Cosentino M; Zaffaroni M; Ferrari M; Marino F; Bombelli R; Rasini E; Frigo G; Ghezzi A; Comi G; Lecchini S
J Neuroimmunol; 2005 May; 162(1-2):112-21. PubMed ID: 15833366
[TBL] [Abstract][Full Text] [Related]
36. Interferon inducers.
de Clercq E
Antibiot Chemother (1971); 1980; 27():251-87. PubMed ID: 6996608
[No Abstract] [Full Text] [Related]
37. [Structure and biological activity of low-molecular interferon inducers].
Chizhov NP; Borisova MA
Antibiot Med Biotekhnol; 1987 Sep; 32(9):706-15. PubMed ID: 3324954
[No Abstract] [Full Text] [Related]
38. [HETEROGENICITY OF ENZYMES].
SZUMIEL I
Postepy Biochem; 1963; 9():153-72. PubMed ID: 14048516
[No Abstract] [Full Text] [Related]
39. Heterogenicity of the immune interferon (IFN-gamma).
Georgiades JA
Tex Rep Biol Med; 1981-1982; 41():260-70. PubMed ID: 6184813
[No Abstract] [Full Text] [Related]
40. Purification and properties of murine interferon.
Kawade Y
Tex Rep Biol Med; 1981-1982; 41():219-24. PubMed ID: 6184807
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
